Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands		Total	Convertible Preferred Stock	Preferred Stock Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (loss) Income
Balance, before retroactive conversion		$ (55,692)		$ 87,140	$ 2	$ 6,521	$ (62,215)	$ 0
Retroactive application					$ (1)	1
Retroactive application, shares	[1]			(152,677,720)	(17,972,432)
Balance, before retroactive conversion, shares	[1]			199,145,285	23,442,353
Beginning balance at Dec. 31, 2022		(55,692)		$ 87,140	$ 1	6,522	(62,215)	0
Beginning balance, shares at Dec. 31, 2022	[1]			46,467,565	5,469,921
Issuance of common stock upon exercise of stock options		92				92
Issuance of common stock upon exercise of stock options, shares	[1]				140,545
Stock-based compensation expense		366				366
Issuance of common stock in connection with the acquisition of fSight, shares	[1]				1,306,385
Issuance of common stock in connection with the acquisition of fSight		10,077				10,077
Unrealized gain (loss) resulting from change in fair value of marketable securities		14						14
Net (loss) income		6,910					6,910
Ending balance, shares at Mar. 31, 2023	[1]			46,467,565	6,916,851
Ending balance at Mar. 31, 2023		(38,233)		$ 87,140	$ 1	17,057	(55,305)	14
Beginning balance at Dec. 31, 2022		(55,692)		$ 87,140	$ 1	6,522	(62,215)	0
Beginning balance, shares at Dec. 31, 2022	[1]			46,467,565	5,469,921
Net (loss) income		13,790
Ending balance, shares at Sep. 30, 2023	[1]				58,733,366
Ending balance at Sep. 30, 2023		75,827			$ 6	136,983	(61,006)	(156)
Beginning balance at Mar. 31, 2023		(38,233)		$ 87,140	$ 1	17,057	(55,305)	14
Beginning balance, shares at Mar. 31, 2023	[1]			46,467,565	6,916,851
Issuance of common stock upon exercise of stock options		14				14
Issuance of common stock upon exercise of stock options, shares	[1]				10,784
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes		(91)				(91)
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes, shares	[1]				(11,832)
Stock-based compensation expense		497				497
Unrealized gain (loss) resulting from change in fair value of marketable securities		(195)						(195)
Convertible preferred stock dividends, shares	[1]			1,258,055
Convertible preferred stock dividends						12,581	(12,581)
Issuance of preferred stock upon exercise of preferred warrants		2,008				2,008
Issuance of preferred stock upon exercise of preferred warrants, shares	[1]		193,372
Conversion of convertible preferred stock into common stock in connection with the Business Combination		87,140	$ (87,140)		$ 5	87,135
Conversion of convertible preferred stock into common stock in connection with the Business Combination, shares	[1]		(47,918,992)		47,918,992
Issuance of common stock upon exercise of common warrants, shares	[1]				1,491,229
Purchase price adjustment in connection with the fSight acquisition		897				897
Issuance of common stock upon Business Combination, shares					1,818,519
Issuance of common stock upon Business Combination, value		573				573
Net (loss) income		(22,176)					(22,176)
Ending balance, shares at Jun. 30, 2023	[1]			0	58,144,543
Ending balance at Jun. 30, 2023		30,434		$ 0	$ 6	120,671	(90,062)	(181)
Issuance of common stock upon exercise of stock options		106				106
Issuance of common stock upon exercise of stock options, shares	[1]				264,277
Issuance of common stock upon exercise of common stock warrants, net of issuance costs and payments to warrant holders of non-redeemed warrants		3,653				3,653
Issuance of common stock upon exercise of common stock warrants, net of issuance costs and payments to warrant holders of non-redeemed warrants, shares	[1]				324,546
Reclassification of convertible note derivative liability to equity		11,279				11,279
Stock-based compensation expense		1,274				1,274
Unrealized gain (loss) resulting from change in fair value of marketable securities		25						25
Net (loss) income		29,056					29,056
Ending balance, shares at Sep. 30, 2023	[1]				58,733,366
Ending balance at Sep. 30, 2023		75,827			$ 6	136,983	(61,006)	(156)
Beginning balance at Dec. 31, 2023		62,824			$ 6	138,657	(75,780)	(59)
Beginning balance, shares at Dec. 31, 2023					58,751,666
Issuance of common stock upon exercise of stock options		250				250
Issuance of common stock upon exercise of stock options, shares					755,016
Stock-based compensation expense		2,505				2,505
Issuance of common stock in connection with the acquisition of fSight, shares					166,271
Issuance of common stock in connection with the acquisition of fSight		239				239
Issuance of common stock in connection with employee incentive restricted stock awards, shares					685,213
Unrealized gain (loss) resulting from change in fair value of marketable securities		12						12
Net (loss) income		(11,506)					(11,506)
Ending balance, shares at Mar. 31, 2024					60,358,166
Ending balance at Mar. 31, 2024		54,324			$ 6	141,651	(87,286)	(47)
Beginning balance at Dec. 31, 2023		$ 62,824			$ 6	138,657	(75,780)	(59)
Beginning balance, shares at Dec. 31, 2023					58,751,666
Issuance of common stock upon exercise of stock options, shares		788,899
Net (loss) income		$ (35,944)
Ending balance, shares at Sep. 30, 2024					60,743,061
Ending balance at Sep. 30, 2024		33,469			$ 6	145,184	(111,724)	3
Beginning balance at Mar. 31, 2024		54,324			$ 6	141,651	(87,286)	(47)
Beginning balance, shares at Mar. 31, 2024					60,358,166
Issuance of common stock upon exercise of stock options		10				10
Issuance of common stock upon exercise of stock options, shares					13,821
Stock-based compensation expense		1,703				1,703
Unrealized gain (loss) resulting from change in fair value of marketable securities		24						24
Net (loss) income		(11,321)					(11,321)
Ending balance, shares at Jun. 30, 2024					60,371,987
Ending balance at Jun. 30, 2024		44,740			$ 6	143,364	(98,607)	(23)
Issuance of common stock upon exercise of stock options		12				12
Issuance of common stock upon exercise of stock options, shares					20,062
Stock-based compensation expense		1,786				1,786
Issuance of common stock in connection with the acquisition of fSight, shares					86,017
Issuance of common stock in connection with the acquisition of fSight		136				136
Issuance of common stock in connection with employee incentive restricted stock awards, shares					362,458
Shares withheld for taxes upon restricted stock awards vesting		(114)				(114)
Shares withheld for taxes upon restricted stock awards vesting, shares					(97,463)
Unrealized gain (loss) resulting from change in fair value of marketable securities		26						26
Net (loss) income		(13,117)					(13,117)
Ending balance, shares at Sep. 30, 2024					60,743,061
Ending balance at Sep. 30, 2024		$ 33,469			$ 6	$ 145,184	$ (111,724)	$ 3

[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.233335 established in the Business Combination as described in Note 3.